ID   SGK3_HUMAN              Reviewed;         496 AA.
AC   Q96BR1; A8K5W3; B3KQC2; Q9P1Q7; Q9UKG5;
DT   22-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   15-MAR-2017, entry version 157.
DE   RecName: Full=Serine/threonine-protein kinase Sgk3;
DE            EC=2.7.11.1;
DE   AltName: Full=Cytokine-independent survival kinase;
DE   AltName: Full=Serum/glucocorticoid-regulated kinase 3;
DE   AltName: Full=Serum/glucocorticoid-regulated kinase-like;
GN   Name=SGK3; Synonyms=CISK, SGKL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PHOSPHORYLATION AT THR-320,
RP   AND MUTAGENESIS OF SER-486.
RX   PubMed=10548550; DOI=10.1042/bj3440189;
RA   Kobayashi T., Deak M., Morrice N., Cohen P.;
RT   "Characterization of the structure and regulation of two novel
RT   isoforms of serum- and glucocorticoid-induced protein kinase.";
RL   Biochem. J. 344:189-197(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10585774; DOI=10.1006/geno.1999.5969;
RA   Dai F., Yu L., He H., Zhao Y., Yang J., Zhang X., Zhao S.;
RT   "Cloning and mapping of a novel human Serum/Glucocorticoid regulated
RT   kinase-like gene, SGKL, to chromosome 8q12.3-q13.1.";
RL   Genomics 62:95-97(1999).
RN   [3]
RP   SEQUENCE REVISION.
RA   Zhao Y.;
RL   Submitted (DEC-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION IN PHOSPHORYLATION OF GSK3B, AND INTERACTION WITH GSK3B.
RX   PubMed=12054501; DOI=10.1016/S0006-291X(02)00349-2;
RA   Dai F., Yu L., He H., Chen Y., Yu J., Yang Y., Xu Y., Ling W.,
RA   Zhao S.;
RT   "Human serum and glucocorticoid-inducible kinase-like kinase (SGKL)
RT   phosphorylates glycogen syntheses kinase 3 beta (GSK-3beta) at serine-
RT   9 through direct interaction.";
RL   Biochem. Biophys. Res. Commun. 293:1191-1196(2002).
RN   [8]
RP   FUNCTION IN REGULATION OF NA(+)/K(+) ATPASE.
RX   PubMed=12590200; DOI=10.1159/000068699;
RA   Henke G., Setiawan I., Boehmer C., Lang F.;
RT   "Activation of Na+/K+-ATPase by the serum and glucocorticoid-dependent
RT   kinase isoforms.";
RL   Kidney Blood Press. Res. 25:370-374(2002).
RN   [9]
RP   FUNCTION.
RX   PubMed=12397388; DOI=10.1007/s00424-002-0873-2;
RA   Gamper N., Fillon S., Feng Y., Friedrich B., Lang P.A., Henke G.,
RA   Huber S.M., Kobayashi T., Cohen P., Lang F.;
RT   "K(+) channel activation by all three isoforms of serum- and
RT   glucocorticoid-dependent protein kinase SGK.";
RL   Pflugers Arch. 445:60-66(2002).
RN   [10]
RP   FUNCTION IN REGULATION OF SCN5A.
RX   PubMed=12650886; DOI=10.1016/S0008-6363(02)00837-4;
RA   Boehmer C., Wilhelm V., Palmada M., Wallisch S., Henke G.,
RA   Brinkmeier H., Cohen P., Pieske B., Lang F.;
RT   "Serum and glucocorticoid inducible kinases in the regulation of the
RT   cardiac sodium channel SCN5A.";
RL   Cardiovasc. Res. 57:1079-1084(2003).
RN   [11]
RP   FUNCTION IN REGULATION OF SLC1A3/EAAT1.
RX   PubMed=12911626;
RA   Boehmer C., Henke G., Schniepp R., Palmada M., Rothstein J.D.,
RA   Broeer S., Lang F.;
RT   "Regulation of the glutamate transporter EAAT1 by the ubiquitin ligase
RT   Nedd4-2 and the serum and glucocorticoid-inducible kinase isoforms
RT   SGK1/3 and protein kinase B.";
RL   J. Neurochem. 86:1181-1188(2003).
RN   [12]
RP   FUNCTION IN REGULATION OF KCNE1 AND KCNQ1.
RX   PubMed=12634932; DOI=10.1007/s00424-002-0982-y;
RA   Embark H.M., Boehmer C., Vallon V., Luft F., Lang F.;
RT   "Regulation of KCNE1-dependent K(+) current by the serum and
RT   glucocorticoid-inducible kinase (SGK) isoforms.";
RL   Pflugers Arch. 445:601-606(2003).
RN   [13]
RP   FUNCTION IN REGULATION OF SCNN1A/ENAC.
RX   PubMed=12632189; DOI=10.1007/s00424-002-0993-8;
RA   Friedrich B., Feng Y., Cohen P., Risler T., Vandewalle A., Broeer S.,
RA   Wang J., Pearce D., Lang F.;
RT   "The serine/threonine kinases SGK2 and SGK3 are potent stimulators of
RT   the epithelial Na+ channel alpha,beta,gamma-ENaC.";
RL   Pflugers Arch. 445:693-696(2003).
RN   [14]
RP   FUNCTION IN REGULATION OF SLC34A2/NAPI-2B, AND FUNCTION IN
RP   PHOSPHORYLATION OF NEDD4L.
RX   PubMed=15044175; DOI=10.1152/ajpgi.00121.2003;
RA   Palmada M., Dieter M., Speil A., Boehmer C., Mack A.F., Wagner H.J.,
RA   Klingel K., Kandolf R., Murer H., Biber J., Closs E.I., Lang F.;
RT   "Regulation of intestinal phosphate cotransporter NaPi IIb by
RT   ubiquitin ligase Nedd4-2 and by serum- and glucocorticoid-dependent
RT   kinase 1.";
RL   Am. J. Physiol. 287:G143-G150(2004).
RN   [15]
RP   FUNCTION IN REGULATION OF SLC13A2/NADC1.
RX   PubMed=14706641; DOI=10.1016/j.bbrc.2003.12.011;
RA   Boehmer C., Embark H.M., Bauer A., Palmada M., Yun C.H., Weinman E.J.,
RA   Endou H., Cohen P., Lahme S., Bichler K.H., Lang F.;
RT   "Stimulation of renal Na+ dicarboxylate cotransporter 1 by Na+/H+
RT   exchanger regulating factor 2, serum and glucocorticoid inducible
RT   kinase isoforms, and protein kinase B.";
RL   Biochem. Biophys. Res. Commun. 313:998-1003(2004).
RN   [16]
RP   FUNCTION IN REGULATION OF TRPV5.
RX   PubMed=15319523; DOI=10.1159/000080329;
RA   Embark H.M., Setiawan I., Poppendieck S., van de Graaf S.F.,
RA   Boehmer C., Palmada M., Wieder T., Gerstberger R., Cohen P., Yun C.C.,
RA   Bindels R.J., Lang F.;
RT   "Regulation of the epithelial Ca2+ channel TRPV5 by the NHE regulating
RT   factor NHERF2 and the serum and glucocorticoid inducible kinase
RT   isoforms SGK1 and SGK3 expressed in Xenopus oocytes.";
RL   Cell. Physiol. Biochem. 14:203-212(2004).
RN   [17]
RP   INTERACTION WITH PDPK1, AND PHOSPHORYLATION BY PDPK1.
RX   PubMed=14604990; DOI=10.1074/jbc.M309653200;
RA   Nilsen T., Slagsvold T., Skjerpen C.S., Brech A., Stenmark H.,
RA   Olsnes S.;
RT   "Peroxisomal targeting as a tool for assaying protein-protein
RT   interactions in the living cell: cytokine-independent survival kinase
RT   (CISK) binds PDK-1 in vivo in a phosphorylation-dependent manner.";
RL   J. Biol. Chem. 279:4794-4801(2004).
RN   [18]
RP   FUNCTION IN REGULATION OF KCNA3/KV1.3.
RX   PubMed=15040001; DOI=10.1002/jcp.10430;
RA   Henke G., Maier G., Wallisch S., Boehmer C., Lang F.;
RT   "Regulation of the voltage gated K+ channel Kv1.3 by the ubiquitin
RT   ligase Nedd4-2 and the serum and glucocorticoid inducible kinase
RT   SGK1.";
RL   J. Cell. Physiol. 199:194-199(2004).
RN   [19]
RP   FUNCTION IN REGULATION OF BSND.
RX   PubMed=15496163; DOI=10.1111/j.1523-1755.2004.00966.x;
RA   Embark H.M., Boehmer C., Palmada M., Rajamanickam J., Wyatt A.W.,
RA   Wallisch S., Capasso G., Waldegger P., Seyberth H.W., Waldegger S.,
RA   Lang F.;
RT   "Regulation of CLC-Ka/barttin by the ubiquitin ligase Nedd4-2 and the
RT   serum- and glucocorticoid-dependent kinases.";
RL   Kidney Int. 66:1918-1925(2004).
RN   [20]
RP   FUNCTION IN REGULATION OF SLC1A5/ASCT2.
RX   PubMed=15845389; DOI=10.1016/j.bbrc.2005.03.159;
RA   Palmada M., Speil A., Jeyaraj S., Boehmer C., Lang F.;
RT   "The serine/threonine kinases SGK1, 3 and PKB stimulate the amino acid
RT   transporter ASCT2.";
RL   Biochem. Biophys. Res. Commun. 331:272-277(2005).
RN   [21]
RP   FUNCTION IN REGULATION OF SLC1A7/EAAT5.
RX   PubMed=15737648; DOI=10.1016/j.bbrc.2005.02.035;
RA   Boehmer C., Rajamanickam J., Schniepp R., Kohler K., Wulff P.,
RA   Kuhl D., Palmada M., Lang F.;
RT   "Regulation of the excitatory amino acid transporter EAAT5 by the
RT   serum and glucocorticoid dependent kinases SGK1 and SGK3.";
RL   Biochem. Biophys. Res. Commun. 329:738-742(2005).
RN   [22]
RP   FUNCTION IN REGULATION OF SLC6A8.
RX   PubMed=16036218; DOI=10.1016/j.bbrc.2005.06.164;
RA   Shojaiefard M., Christie D.L., Lang F.;
RT   "Stimulation of the creatine transporter SLC6A8 by the protein kinases
RT   SGK1 and SGK3.";
RL   Biochem. Biophys. Res. Commun. 334:742-746(2005).
RN   [23]
RP   FUNCTION IN REGULATION OF KCNH2/HERG.
RX   PubMed=17167223; DOI=10.1159/000097666;
RA   Maier G., Palmada M., Rajamanickam J., Shumilina E., Boehmer C.,
RA   Lang F.;
RT   "Upregulation of HERG channels by the serum and glucocorticoid
RT   inducible kinase isoform SGK3.";
RL   Cell. Physiol. Biochem. 18:177-186(2006).
RN   [24]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH ITHC/AIP4, AND
RP   PHOSPHORYLATION AT SER-486.
RX   PubMed=16888620; DOI=10.1038/sj.emboj.7601267;
RA   Slagsvold T., Marchese A., Brech A., Stenmark H.;
RT   "CISK attenuates degradation of the chemokine receptor CXCR4 via the
RT   ubiquitin ligase AIP4.";
RL   EMBO J. 25:3738-3749(2006).
RN   [25]
RP   PHOSPHORYLATION AT THR-320 AND SER-486, AND MUTAGENESIS OF ARG-90 AND
RP   LYS-191.
RX   PubMed=16790420; DOI=10.1074/jbc.M604333200;
RA   Tessier M., Woodgett J.R.;
RT   "Role of the Phox homology domain and phosphorylation in activation of
RT   serum and glucocorticoid-regulated kinase-3.";
RL   J. Biol. Chem. 281:23978-23989(2006).
RN   [26]
RP   FUNCTION IN REGULATION OF TRPV6.
RX   PubMed=18005662; DOI=10.1016/j.febslet.2007.11.006;
RA   Boehmer C., Palmada M., Kenngott C., Lindner R., Klaus F., Laufer J.,
RA   Lang F.;
RT   "Regulation of the epithelial calcium channel TRPV6 by the serum and
RT   glucocorticoid-inducible kinase isoforms SGK1 and SGK3.";
RL   FEBS Lett. 581:5586-5590(2007).
RN   [27]
RP   FUNCTION IN PHOSPHORYLATION OF FLII, AND INTERACTION WITH FLII.
RX   PubMed=19293151; DOI=10.1074/jbc.M807770200;
RA   Xu J., Liao L., Qin J., Xu J., Liu D., Songyang Z.;
RT   "Identification of Flightless-I as a substrate of the cytokine-
RT   independent survival kinase CISK.";
RL   J. Biol. Chem. 284:14377-14385(2009).
RN   [28]
RP   FUNCTION IN REGULATION OF SLC6A19.
RX   PubMed=20511718; DOI=10.1159/000315092;
RA   Boehmer C., Sopjani M., Klaus F., Lindner R., Laufer J., Jeyaraj S.,
RA   Lang F., Palmada M.;
RT   "The serum and glucocorticoid inducible kinases SGK1-3 stimulate the
RT   neutral amino acid transporter SLC6A19.";
RL   Cell. Physiol. Biochem. 25:723-732(2010).
RN   [29]
RP   FUNCTION IN REGULATION OF SLC9A3/NHE3, AND SUBCELLULAR LOCATION.
RX   PubMed=21865597; DOI=10.1091/mbc.E11-04-0328;
RA   He P., Lee S.J., Lin S., Seidler U., Lang F., Fejes-Toth G.,
RA   Naray-Fejes-Toth A., Yun C.C.;
RT   "Serum- and glucocorticoid-induced kinase 3 in recycling endosomes
RT   mediates acute activation of Na+/H+ exchanger NHE3 by
RT   glucocorticoids.";
RL   Mol. Biol. Cell 22:3812-3825(2011).
RN   [30]
RP   INDUCTION, AND TISSUE SPECIFICITY.
RX   PubMed=21084382; DOI=10.1210/me.2010-0294;
RA   Wang Y., Zhou D., Phung S., Masri S., Smith D., Chen S.;
RT   "SGK3 is an estrogen-inducible kinase promoting estrogen-mediated
RT   survival of breast cancer cells.";
RL   Mol. Endocrinol. 25:72-82(2011).
RN   [31]
RP   REVIEW.
RX   PubMed=16460280; DOI=10.1146/annurev.physiol.68.040104.131654;
RA   Loffing J., Flores S.Y., Staub O.;
RT   "Sgk kinases and their role in epithelial transport.";
RL   Annu. Rev. Physiol. 68:461-490(2006).
RN   [32]
RP   REVIEW ON FUNCTION.
RX   PubMed=20919962; DOI=10.3109/08977194.2010.518616;
RA   Bruhn M.A., Pearson R.B., Hannan R.D., Sheppard K.E.;
RT   "Second AKT: the rise of SGK in cancer signalling.";
RL   Growth Factors 28:394-408(2010).
RN   [33]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-92.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [34]
RP   VARIANT [LARGE SCALE ANALYSIS] PRO-355.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase which is involved in the
CC       regulation of a wide variety of ion channels, membrane
CC       transporters, cell growth, proliferation, survival and migration.
CC       Up-regulates Na(+) channels: SCNN1A/ENAC and SCN5A, K(+) channels:
CC       KCNA3/KV1.3, KCNE1, KCNQ1 and KCNH2/HERG, epithelial Ca(2+)
CC       channels: TRPV5 and TRPV6, chloride channel: BSND, creatine
CC       transporter: SLC6A8, Na(+)/dicarboxylate cotransporter:
CC       SLC13A2/NADC1, Na(+)-dependent phosphate cotransporter:
CC       SLC34A2/NAPI-2B, amino acid transporters: SLC1A5/ASCT2 and
CC       SLC6A19, glutamate transporters: SLC1A3/EAAT1, SLC1A6/EAAT4 and
CC       SLC1A7/EAAT5, glutamate receptors: GRIA1/GLUR1 and GRIK2/GLUR6,
CC       Na(+)/H(+) exchanger: SLC9A3/NHE3, and the Na(+)/K(+) ATPase.
CC       Plays a role in the regulation of renal tubular phosphate
CC       transport and bone density. Phosphorylates NEDD4L and GSK3B.
CC       Positively regulates ER transcription activity through
CC       phosphorylation of FLII. Negatively regulates the function of
CC       ITCH/AIP4 via its phosphorylation and thereby prevents CXCR4 from
CC       being efficiently sorted to lysosomes.
CC       {ECO:0000269|PubMed:12054501, ECO:0000269|PubMed:12397388,
CC       ECO:0000269|PubMed:12590200, ECO:0000269|PubMed:12632189,
CC       ECO:0000269|PubMed:12634932, ECO:0000269|PubMed:12650886,
CC       ECO:0000269|PubMed:12911626, ECO:0000269|PubMed:14706641,
CC       ECO:0000269|PubMed:15040001, ECO:0000269|PubMed:15044175,
CC       ECO:0000269|PubMed:15319523, ECO:0000269|PubMed:15496163,
CC       ECO:0000269|PubMed:15737648, ECO:0000269|PubMed:15845389,
CC       ECO:0000269|PubMed:16036218, ECO:0000269|PubMed:16888620,
CC       ECO:0000269|PubMed:17167223, ECO:0000269|PubMed:18005662,
CC       ECO:0000269|PubMed:19293151, ECO:0000269|PubMed:20511718,
CC       ECO:0000269|PubMed:21865597}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Two specific sites, one in the kinase domain
CC       (Thr-320) and the other in the C-terminal regulatory region (Ser-
CC       486), need to be phosphorylated for its full activation.
CC   -!- SUBUNIT: Interacts with GSK3B and FLII. Interacts with PDPK1 in a
CC       phosphorylation-dependent manner. {ECO:0000269|PubMed:12054501,
CC       ECO:0000269|PubMed:14604990, ECO:0000269|PubMed:16888620,
CC       ECO:0000269|PubMed:19293151}.
CC   -!- INTERACTION:
CC       Q96J02:ITCH; NbExp=5; IntAct=EBI-2801236, EBI-1564678;
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle {ECO:0000250}. Early
CC       endosome. Recycling endosome. Note=Endosomal localization is a
CC       prerequisite for complete kinase activity. It is essential for its
CC       colocalization with the kinase responsible for phosphorylating
CC       Ser-486 thus allowing PDPK1 phosphorylation of Thr-320 resulting
CC       in complete activation of SGK3. Localized in vesicle-like
CC       structures and in the early endosome. Colocalizes with SLC9A3/NHE3
CC       in the recycling endosomes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96BR1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96BR1-2; Sequence=VSP_041903;
CC   -!- TISSUE SPECIFICITY: Expressed in most tissues with highest levels
CC       in pancreas, kidney liver, heart and brain and lower levels in
CC       lung, placenta and skeletal muscle. Expression is higher in ER-
CC       positive breast tumors than ER-negative breast tumors.
CC       {ECO:0000269|PubMed:21084382}.
CC   -!- INDUCTION: Induced by estrogen/ER in breast cancer cells.
CC       {ECO:0000269|PubMed:21084382}.
CC   -!- PTM: Activated by phosphorylation on Ser-486 by an unknown kinase
CC       (may be mTORC2 but not confirmed), transforming it into a
CC       substrate for PDPK1 which then phosphorylates it on Thr-320.
CC       {ECO:0000269|PubMed:10548550, ECO:0000269|PubMed:14604990,
CC       ECO:0000269|PubMed:16790420, ECO:0000269|PubMed:16888620}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF12758.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF169035; AAF12758.1; ALT_INIT; mRNA.
DR   EMBL; AF085233; AAF27051.2; -; mRNA.
DR   EMBL; AK074666; BAG51984.1; -; mRNA.
DR   EMBL; AK291428; BAF84117.1; -; mRNA.
DR   EMBL; AC011031; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090154; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471068; EAW86919.1; -; Genomic_DNA.
DR   EMBL; BC015326; AAH15326.1; -; mRNA.
DR   CCDS; CCDS6195.1; -. [Q96BR1-1]
DR   CCDS; CCDS6196.1; -. [Q96BR1-2]
DR   RefSeq; NP_001028750.1; NM_001033578.2. [Q96BR1-1]
DR   RefSeq; NP_001191102.1; NM_001204173.1. [Q96BR1-1]
DR   RefSeq; NP_037389.4; NM_013257.4. [Q96BR1-1]
DR   RefSeq; NP_733827.2; NM_170709.2. [Q96BR1-2]
DR   UniGene; Hs.613417; -.
DR   UniGene; Hs.733251; -.
DR   ProteinModelPortal; Q96BR1; -.
DR   SMR; Q96BR1; -.
DR   BioGrid; 117195; 8.
DR   IntAct; Q96BR1; 6.
DR   MINT; MINT-2813751; -.
DR   STRING; 9606.ENSP00000262211; -.
DR   BindingDB; Q96BR1; -.
DR   ChEMBL; CHEMBL6186; -.
DR   GuidetoPHARMACOLOGY; 1536; -.
DR   iPTMnet; Q96BR1; -.
DR   PhosphoSitePlus; Q96BR1; -.
DR   BioMuta; SGK3; -.
DR   DMDM; 28558163; -.
DR   MaxQB; Q96BR1; -.
DR   PaxDb; Q96BR1; -.
DR   PeptideAtlas; Q96BR1; -.
DR   PRIDE; Q96BR1; -.
DR   DNASU; 23678; -.
DR   Ensembl; ENST00000345714; ENSP00000331816; ENSG00000104205. [Q96BR1-1]
DR   Ensembl; ENST00000396596; ENSP00000379842; ENSG00000104205. [Q96BR1-1]
DR   Ensembl; ENST00000520976; ENSP00000430691; ENSG00000104205. [Q96BR1-2]
DR   Ensembl; ENST00000521198; ENSP00000430463; ENSG00000104205. [Q96BR1-1]
DR   Ensembl; ENST00000522398; ENSP00000430256; ENSG00000104205. [Q96BR1-1]
DR   GeneID; 100533105; -.
DR   GeneID; 23678; -.
DR   KEGG; hsa:100533105; -.
DR   KEGG; hsa:23678; -.
DR   UCSC; uc003xwp.4; human. [Q96BR1-1]
DR   CTD; 100533105; -.
DR   CTD; 23678; -.
DR   DisGeNET; 23678; -.
DR   GeneCards; SGK3; -.
DR   HGNC; HGNC:10812; SGK3.
DR   HPA; HPA027146; -.
DR   MIM; 607591; gene.
DR   neXtProt; NX_Q96BR1; -.
DR   OpenTargets; ENSG00000104205; -.
DR   PharmGKB; PA35722; -.
DR   eggNOG; KOG0598; Eukaryota.
DR   eggNOG; KOG2101; Eukaryota.
DR   eggNOG; ENOG410XNPH; LUCA.
DR   GeneTree; ENSGT00860000133668; -.
DR   HOGENOM; HOG000233033; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; Q96BR1; -.
DR   KO; K13304; -.
DR   OMA; FTEEMVP; -.
DR   OrthoDB; EOG091G06FF; -.
DR   PhylomeDB; Q96BR1; -.
DR   TreeFam; TF320906; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   SignaLink; Q96BR1; -.
DR   SIGNOR; Q96BR1; -.
DR   GeneWiki; SGK3; -.
DR   PRO; PR:Q96BR1; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000104205; -.
DR   CleanEx; HS_SGK2; -.
DR   CleanEx; HS_SGK3; -.
DR   ExpressionAtlas; Q96BR1; baseline and differential.
DR   Genevisible; Q96BR1; HS.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005769; C:early endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0055037; C:recycling endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005246; F:calcium channel regulator activity; TAS:UniProtKB.
DR   GO; GO:0017081; F:chloride channel regulator activity; TAS:UniProtKB.
DR   GO; GO:0035091; F:phosphatidylinositol binding; IEA:InterPro.
DR   GO; GO:0015459; F:potassium channel regulator activity; TAS:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0017080; F:sodium channel regulator activity; TAS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0032411; P:positive regulation of transporter activity; IBA:GO_Central.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0042981; P:regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0001558; P:regulation of cell growth; TAS:UniProtKB.
DR   GO; GO:0030334; P:regulation of cell migration; TAS:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell proliferation; TAS:UniProtKB.
DR   GO; GO:0051090; P:regulation of sequence-specific DNA binding transcription factor activity; TAS:UniProtKB.
DR   GO; GO:0006950; P:response to stress; TAS:ProtInc.
DR   Gene3D; 3.30.1520.10; -; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR001683; Phox.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   Pfam; PF00787; PX; 1.
DR   SMART; SM00312; PX; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF64268; SSF64268; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50195; PX; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasmic vesicle; Endosome; Kinase; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    496       Serine/threonine-protein kinase Sgk3.
FT                                /FTId=PRO_0000086649.
FT   DOMAIN       12    124       PX. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00147}.
FT   DOMAIN      162    419       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      420    496       AGC-kinase C-terminal.
FT   NP_BIND     168    176       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOTIF       195    205       Nuclear localization signal.
FT                                {ECO:0000250}.
FT   ACT_SITE    286    286       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     191    191       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     126    126       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9ERE3}.
FT   MOD_RES     129    129       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9ERE3}.
FT   MOD_RES     142    142       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O00141}.
FT   MOD_RES     320    320       Phosphothreonine; by PDPK1.
FT                                {ECO:0000269|PubMed:10548550,
FT                                ECO:0000269|PubMed:16790420}.
FT   MOD_RES     461    461       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O00141}.
FT   MOD_RES     465    465       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O00141}.
FT   MOD_RES     486    486       Phosphoserine.
FT                                {ECO:0000269|PubMed:16790420,
FT                                ECO:0000269|PubMed:16888620}.
FT   VAR_SEQ     327    358       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041903.
FT   VARIANT      92     92       A -> V (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035636.
FT   VARIANT     355    355       L -> P (in dbSNP:rs750700898).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041076.
FT   MUTAGEN      90     90       R->A: Partially localized to the
FT                                membrane. {ECO:0000269|PubMed:16790420}.
FT   MUTAGEN     191    191       K->M: Abolishes activity.
FT                                {ECO:0000269|PubMed:16790420}.
FT   MUTAGEN     486    486       S->D: Increased activation.
FT                                {ECO:0000269|PubMed:10548550}.
FT   CONFLICT     54     54       F -> V (in Ref. 2; AAF27051).
FT                                {ECO:0000305}.
FT   CONFLICT    127    127       D -> G (in Ref. 2; AAF27051).
FT                                {ECO:0000305}.
FT   CONFLICT    187    187       F -> V (in Ref. 2; AAF27051).
FT                                {ECO:0000305}.
FT   CONFLICT    294    294       L -> V (in Ref. 2; AAF27051).
FT                                {ECO:0000305}.
FT   CONFLICT    387    387       T -> R (in Ref. 2; AAF27051).
FT                                {ECO:0000305}.
SQ   SEQUENCE   496 AA;  57108 MW;  76A6CCEB69006CF1 CRC64;
     MQRDHTMDYK ESCPSVSIPS SDEHREKKKR FTVYKVLVSV GRSEWFVFRR YAEFDKLYNT
     LKKQFPAMAL KIPAKRIFGD NFDPDFIKQR RAGLNEFIQN LVRYPELYNH PDVRAFLQMD
     SPKHQSDPSE DEDERSSQKL HSTSQNINLG PSGNPHAKPT DFDFLKVIGK GSFGKVLLAK
     RKLDGKFYAV KVLQKKIVLN RKEQKHIMAE RNVLLKNVKH PFLVGLHYSF QTTEKLYFVL
     DFVNGGELFF HLQRERSFPE HRARFYAAEI ASALGYLHSI KIVYRDLKPE NILLDSVGHV
     VLTDFGLCKE GIAISDTTTT FCGTPEYLAP EVIRKQPYDN TVDWWCLGAV LYEMLYGLPP
     FYCRDVAEMY DNILHKPLSL RPGVSLTAWS ILEELLEKDR QNRLGAKEDF LEIQNHPFFE
     SLSWADLVQK KIPPPFNPNV AGPDDIRNFD TAFTEETVPY SVCVSSDYSI VNASVLEADD
     AFVGFSYAPP SEDLFL
//
